Mary Wallace - Concepedia

Author

Mary Wallace

Baylor University Medical Center

Also Known As

M. E. Wallace, M. WALLACE, M. Wallace, Mary E. Wallace, Mary Wallace, Wallace, Mary

Publications

768

Citations

H-Index

Concepts

All Affiliations

Baylor University Medical Center Medical Research Council Columbia University Irving Medical Center Dutch Blood Transfusion Society Scottish National Blood Transfusion Service

About

Mary Wallace is an author at Baylor University Medical Center specializing in medicine, pathology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	90
2	Engineering	1	1	100
3	Health Sciences	1	1	12
4	Allergy	1	1	15
5	Clinical Immunology	1	1	12

Mary Wallace

Publications

656

Citations

H-Index

Page 1

	Year	Citations
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings Fanny Mochel, Raphael Schiffmann, Marjan E. Steenweg, Annals of Neurology	2012	152
Origin and classification of springs and historical review with current applications Caryl Alfaro, Mary Wallace Environmental Geology Mechanical EngineeringEngineeringExchange SpringsCurrent Applications	1994	100
Carnitine palmitoyltransferase II deficiency Charles R. Roe, B-Z Yang, Henri Brunengraber, Neurology	2008	93
The genetic basis of a new partial D antigen: D<sup>DBT</sup> Erik A.M. Beckers, B. H. W. Faas, Suat Şimşek, British Journal of Haematology	1996	58
Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways Charles R. Roe, Teodoro Bottiglieri, Mary Wallace, Molecular Genetics and Metabolism Inherited Metabolic DiseasePathologyAnaplerotic Diet TherapyDefective Methylation PathwaysMedicine	2010	45
FPTT is a low‐incidence Rh antigen associated with a “new” partial Rh D phenotype, DFR C. Lomas, W Grässmann, D. S. Ford, Transfusion	1994	43
Deep Intronic<i>GBE1</i>Mutation in Manifesting Heterozygous Patients With Adult Polyglucosan Body Disease Hasan O. Akman, Or Kakhlon, Jorida Çoku, JAMA Neurology	2015	43
A double‐blind, placebo‐controlled trial of triheptanoin in adult polyglucosan body disease and open‐label, long‐term outcome Raphael Schiffmann, Mary Wallace, Daisy Rinaldi, Journal of Inherited Metabolic Disease	2017	22
DBT: a partial D phenotype associated with the low‐incidence antigen Rh32 Mary Wallace, Christine Lomas‐Francis, Erik A.M. Beckers, Transfusion Medicine	1997	20
Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders Charles R. Roe, Diane S. Roe, Mary Wallace, Molecular Genetics and Metabolism Metabolic SyndromeOmega-3 Fatty AcidMedicineLipid NutritionEssential Fat Supplements	2007	18

Page 1